Tri Chemical Laboratories Inc. (TYO:4369)
Japan
· Delayed Price · Currency is JPY 3,215.00
0.00 (0.00%)
Mar 10, 2025, 3:30 PM JST
Tri Chemical Laboratories Income Statement
Financials in millions JPY. Fiscal year is February - January.
Millions JPY. Fiscal year is Feb - Jan.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Oct '24 Oct 31, 2024 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 | Jan '21 Jan 31, 2021 | Jan '20 Jan 31, 2020 | 2019 - 2015 |
| Revenue | 16,136 | 11,246 | 13,803 | 11,574 | 9,801 | 8,267 | Upgrade
|
| Revenue Growth (YoY) | 35.84% | -18.52% | 19.26% | 18.09% | 18.56% | 6.10% | Upgrade
|
| Cost of Revenue | 9,530 | 7,160 | 8,224 | 6,740 | 5,421 | 4,315 | Upgrade
|
| Gross Profit | 6,607 | 4,086 | 5,579 | 4,834 | 4,380 | 3,952 | Upgrade
|
| Selling, General & Admin | 1,794 | 1,410 | 1,439 | 1,305 | 1,177 | 1,105 | Upgrade
|
| Research & Development | 665 | 665 | 569 | 486 | 452 | 484 | Upgrade
|
| Operating Expenses | 2,522 | 2,138 | 2,074 | 1,858 | 1,689 | 1,625 | Upgrade
|
| Operating Income | 4,085 | 1,948 | 3,505 | 2,976 | 2,691 | 2,327 | Upgrade
|
| Interest Expense | -22.51 | -23 | -28 | -31 | -34 | -32 | Upgrade
|
| Interest & Investment Income | 1.78 | 1 | - | - | - | - | Upgrade
|
| Earnings From Equity Investments | 1,107 | 1,036 | 2,409 | 1,936 | 1,540 | 1,324 | Upgrade
|
| Currency Exchange Gain (Loss) | 9.57 | 330 | - | 300 | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 31.17 | 8 | 300 | 129 | 144 | 124 | Upgrade
|
| EBT Excluding Unusual Items | 5,212 | 3,300 | 6,186 | 5,310 | 4,341 | 3,743 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | - | -9 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -24 | -24 | - | -16 | -9 | - | Upgrade
|
| Pretax Income | 5,188 | 3,276 | 6,186 | 5,294 | 4,323 | 3,743 | Upgrade
|
| Income Tax Expense | 1,340 | 806 | 1,354 | 1,199 | 946 | 804 | Upgrade
|
| Net Income | 3,848 | 2,470 | 4,832 | 4,095 | 3,377 | 2,939 | Upgrade
|
| Net Income to Common | 3,848 | 2,470 | 4,832 | 4,095 | 3,377 | 2,939 | Upgrade
|
| Net Income Growth | 66.88% | -48.88% | 18.00% | 21.26% | 14.90% | 29.64% | Upgrade
|
| Shares Outstanding (Basic) | 32 | 32 | 32 | 32 | 31 | 31 | Upgrade
|
| Shares Outstanding (Diluted) | 32 | 32 | 32 | 32 | 31 | 31 | Upgrade
|
| Shares Change (YoY) | -0.00% | -0.00% | 0.25% | 3.74% | -0.00% | -0.00% | Upgrade
|
| EPS (Basic) | 118.42 | 76.01 | 148.69 | 126.33 | 108.07 | 94.06 | Upgrade
|
| EPS (Diluted) | 118.42 | 76.01 | 148.69 | 126.33 | 108.07 | 94.06 | Upgrade
|
| EPS Growth | 66.88% | -48.88% | 17.70% | 16.89% | 14.90% | 29.64% | Upgrade
|
| Free Cash Flow | 1,243 | 1,233 | 4,862 | 2,757 | -835 | 404 | Upgrade
|
| Free Cash Flow Per Share | 38.24 | 37.94 | 149.61 | 85.05 | -26.72 | 12.93 | Upgrade
|
| Dividend Per Share | 30.000 | 30.000 | 30.000 | 20.000 | 17.000 | 14.500 | Upgrade
|
| Dividend Growth | 0% | 0% | 50.00% | 17.65% | 17.24% | 28.89% | Upgrade
|
| Gross Margin | - | 36.33% | 40.42% | 41.77% | 44.69% | 47.80% | Upgrade
|
| Operating Margin | 25.31% | 17.32% | 25.39% | 25.71% | 27.46% | 28.15% | Upgrade
|
| Profit Margin | 23.85% | 21.96% | 35.01% | 35.38% | 34.46% | 35.55% | Upgrade
|
| Free Cash Flow Margin | 7.70% | 10.96% | 35.22% | 23.82% | -8.52% | 4.89% | Upgrade
|
| EBITDA | 5,445 | 3,252 | 4,714 | 3,995 | 3,505 | 2,969 | Upgrade
|
| EBITDA Margin | - | 28.92% | 34.15% | 34.52% | 35.76% | 35.91% | Upgrade
|
| D&A For EBITDA | 1,360 | 1,304 | 1,209 | 1,019 | 814 | 642 | Upgrade
|
| EBIT | 4,085 | 1,948 | 3,505 | 2,976 | 2,691 | 2,327 | Upgrade
|
| EBIT Margin | - | 17.32% | 25.39% | 25.71% | 27.46% | 28.15% | Upgrade
|
| Effective Tax Rate | - | 24.60% | 21.89% | 22.65% | 21.88% | 21.48% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.